Neoplasms by Site Terminated Phase 1 Trials for Indocyanine green (DB16024)

IndicationStatusPhase
DBCOND0030096 (Neoplasms by Site)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02111824A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and TherapyDiagnostic